Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.77 USD | +2.21% | +1.09% | +42.78% |
May. 06 | Sector Update: Health Care Stocks Higher in Late Afternoon Trading | MT |
May. 06 | Lyell Immunopharma Shares Rise After Q1 Net Loss Narrows | MT |
Evolution of the average Target Price on Lyell Immunopharma, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Lyell Immunopharma, Inc.
HC Wainwright | |
JPMorgan Chase | |
Morgan Stanley | |
Goldman Sachs | |
BofA Securities |
EPS Revisions
- Stock Market
- Equities
- LYEL Stock
- Consensus Lyell Immunopharma, Inc.